Author:
Matsumoto Takemasa,Fujita Masaki
Reference81 articles.
1. GBD 2015 Chronic Respiratory Disease Collaborators. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: A systematic analysis for the Global Burden of Disease Study 2015. The Lancet Respiratory Medicine. 2017;5:691-706. DOI: 10.1016/S2213-2600(17)30293-X
2. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Global Initiative for Chronic Obstructive Lung Disease. Available from: http://www.goldcopd.org/
3. Du Q, Jin J, Liu X, Sun Y. Bronchiectasis as a comorbidity of chronic obstructive pulmonary disease: A systematic review and meta-analysis. PLoS One. 2016;11:e0150532. DOI: 10.1371/journal.pone.0150532
4. Ferguson GT, Make B. Management of stable chronic obstructive pulmonary disease. In: Stoller JK, editor. Waltham, MA: UpToDate Inc.; http://www.uptodate.com [Accessed: November 15, 2017]
5. Ross CL, Hansel TT. New drug therapies for COPD. Clinics in Chest Medicine. 2014;35:219-239. DOI: 10.1016/j.ccm.2013.10.003